CeDR Atlas: a knowledgebase of cellular drug response.

Yin-Ying Wang, Hongen Kang, Tianyi Xu, Lili Hao, Yiming Bao, Peilin Jia
Author Information
  1. Yin-Ying Wang: CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
  2. Hongen Kang: CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
  3. Tianyi Xu: China National Center for Bioinformation, Beijing 100101, China.
  4. Lili Hao: China National Center for Bioinformation, Beijing 100101, China. ORCID
  5. Yiming Bao: China National Center for Bioinformation, Beijing 100101, China.
  6. Peilin Jia: CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China. ORCID

Abstract

Drug response to many diseases varies dramatically due to the complex genomics and functional features and contexts. Cellular diversity of human tissues, especially tumors, is one of the major contributing factors to the different drug response in different samples. With the accumulation of single-cell RNA sequencing (scRNA-seq) data, it is now possible to study the drug response to different treatments at the single cell resolution. Here, we present CeDR Atlas (available at https://ngdc.cncb.ac.cn/cedr), a knowledgebase reporting computational inference of cellular drug response for hundreds of cell types from various tissues. We took advantage of the high-throughput profiling of drug-induced gene expression available through the Connectivity Map resource (CMap) as well as hundreds of scRNA-seq data covering cells from a wide variety of organs/tissues, diseases, and conditions. Currently, CeDR maintains the results for more than 582 single cell data objects for human, mouse and cell lines, including about 140 phenotypes and 1250 tissue-cell combination types. All the results can be explored and searched by keywords for drugs, cell types, tissues, diseases, and signature genes. Overall, CeDR fine maps drug response at cellular resolution and sheds lights on the design of combinatorial treatments, drug resistance and even drug side effects.

References

  1. Nat Immunol. 2019 Feb;20(2):163-172 [PMID: 30643263]
  2. PLoS Comput Biol. 2011 Dec;7(12):e1002323 [PMID: 22219721]
  3. Cell. 2010 May 14;141(4):559-63 [PMID: 20478246]
  4. Trends Pharmacol Sci. 2020 Dec;41(12):1050-1065 [PMID: 33153777]
  5. Nucleic Acids Res. 2003 Jan 1;31(1):82-6 [PMID: 12519953]
  6. Nucleic Acids Res. 2021 Jan 8;49(D1):D1029-D1037 [PMID: 32976581]
  7. Nat Rev Clin Oncol. 2018 Feb;15(2):81-94 [PMID: 29115304]
  8. Cell Syst. 2016 Oct 26;3(4):385-394.e3 [PMID: 27693023]
  9. Genome Med. 2021 May 11;13(1):82 [PMID: 33975634]
  10. Nature. 2018 Oct;562(7727):367-372 [PMID: 30283141]
  11. Nat Commun. 2017 Jan 16;8:14049 [PMID: 28091601]
  12. IEEE/ACM Trans Comput Biol Bioinform. 2021 Nov-Dec;18(6):2514-2525 [PMID: 32305934]
  13. Biomed Pharmacother. 2020 Nov;131:110693 [PMID: 32882586]
  14. Nucleic Acids Res. 2021 Jan 8;49(D1):D1502-D1506 [PMID: 33211879]
  15. Nucleic Acids Res. 2020 Jan 8;48(D1):D545-D553 [PMID: 31504765]
  16. Biomed Res Int. 2015;2015:584189 [PMID: 25866796]
  17. Curr Protoc Mol Biol. 2018 Apr;122(1):e57 [PMID: 29851283]
  18. Food Chem Toxicol. 2017 Jan;99:1-8 [PMID: 27838343]
  19. Oncotarget. 2017 Sep 30;8(55):93957-93968 [PMID: 29212201]
  20. Nature. 2020 May;581(7808):303-309 [PMID: 32214235]
  21. Nat Rev Cancer. 2007 Jan;7(1):54-60 [PMID: 17186018]
  22. Nat Neurosci. 2017 Oct;20(10):1342-1349 [PMID: 28805813]
  23. Genome Biol. 2018 Feb 6;19(1):15 [PMID: 29409532]
  24. Front Cell Dev Biol. 2021 Jan 11;8:607209 [PMID: 33505964]
  25. Bioinformatics. 2021 May 10;: [PMID: 33974010]
  26. Genomics Inform. 2021 Mar;19(1):e10 [PMID: 33840174]
  27. Mol Cancer Res. 2020 May;18(5):685-697 [PMID: 32019809]
  28. Phytomedicine. 2019 May;58:152762 [PMID: 31005717]
  29. IEEE/ACM Trans Comput Biol Bioinform. 2019 Jan-Feb;16(1):154-162 [PMID: 29993698]
  30. Nat Commun. 2021 Mar 12;12(1):1628 [PMID: 33712615]
  31. Methods Mol Biol. 2016;1418:93-110 [PMID: 27008011]
  32. Metabolism. 2019 Aug;97:9-17 [PMID: 31108105]
  33. Dig Dis Sci. 2012 Jul;57(7):1764-72 [PMID: 22383081]
  34. Sci Rep. 2017 Mar 15;7:44085 [PMID: 28294141]
  35. Cancer Discov. 2016 Mar;6(3):230-2 [PMID: 26951836]
  36. Nat Genet. 2020 Nov;52(11):1208-1218 [PMID: 33128048]
  37. Nat Genet. 2013 Jun;45(6):580-5 [PMID: 23715323]
  38. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 [PMID: 16199517]
  39. Cell Discov. 2016 Aug 30;2:16025 [PMID: 27625789]
  40. Cell. 2018 May 17;173(5):1307 [PMID: 29775597]
  41. Curr Top Med Chem. 2016;16(30):3629-3635 [PMID: 27334199]
  42. NPJ Precis Oncol. 2020 Jun 15;4:19 [PMID: 32566759]
  43. Nucleic Acids Res. 2022 Jan 7;50(D1):D1016-D1024 [PMID: 34591957]
  44. Cell Res. 2019 Sep;29(9):725-738 [PMID: 31273297]
  45. Nucleic Acids Res. 2021 Jan 8;49(D1):D783-D791 [PMID: 33074335]
  46. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):381-2 [PMID: 11209037]
  47. Oncotarget. 2017 Jun 20;8(25):41113-41124 [PMID: 28467802]
  48. Ann Pharmacother. 2003 Oct;37(10):1438-40 [PMID: 14519046]

MeSH Term

Animals
Biomarkers, Pharmacological
Databases, Factual
Gene Expression Profiling
Humans
Knowledge Bases
Mice
Neoplasms
RNA-Seq
Single-Cell Analysis
Software
Exome Sequencing

Chemicals

Biomarkers, Pharmacological

Links to CNCB-NGDC Resources

Database Commons: DBC007424 (CeDR)

Word Cloud

Similar Articles

Cited By